Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary
greatly in presentation and severity. Besides weakness and sensory disturbances, patients …

Prior to deployment of coronavirus disease 2019 (COVID‐19) vaccines in the European
Union in 2021, a high vaccine uptake leading to an unprecedented volume of safety data …

Importance Because of historical associations between vaccines and Guillain-Barré
syndrome (GBS), the condition was a prespecified adverse event of special interest for …

Vaccination against viruses has rarely been associated with Guillain-Barré syndrome (GBS),
and an association with the COVID-19 vaccine is unknown. We performed a population …

Valid, responsive blood biomarkers specific to peripheral nerve damage would improve
management of peripheral nervous system (PNS) diseases. Neurofilament light chain (NfL) …

Objective. This systematic review aims to synthesize and analyze the available literature on
central nervous system (CNS) magnetic resonance imaging (MRI) findings in individuals …

Abstract Introduction Guillain-Barré syndrome (GBS) is a rare but serious condition that
carries with it a high rate of morbidity and mortality. Objective This review highlights the …

Background and Objectives Existing data regarding occurrence of Guillain-Barré syndrome
(GBS) after coronavirus disease 2019 (COVID-19) infection and vaccination are …

This study compared the clinical outcomes of the two main neurophysiological types of
Guillain-Barré Syndrome (GBS). Sixty-two GBS patients were examined clinically at onset …

Increasing evidence suggests an association between SARS-CoV-2 vaccines and Guillain–
Barré syndrome (GBS). Nevertheless, little is understood about the contributing risk factors …